WH Plan To Tackle COVID Hinges On Quick Reviews, Small Trials, Funding

By Beth Wang / March 2, 2022 at 3:04 PM
The Biden administration is calling for Congress to provide funding to support streamlined FDA review and development of future COVID-19 vaccines and therapies, including variant-specific products that can be quickly developed, authorized and deployed should they be needed in the future. The funding request is part of the administration’s wide-ranging strategy to tackle COVID-19 going forward, which was laid out in a 96-page report released Wednesday (March 2) . White House COVID-19 Response Coordinator Jeff Zients said the administration will...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.